MOTIF BIOSCIENCES
Motif BioSciences (“Motifâ€) is a population genetics company seeking to identify the genetic causes of major diseases by working with a unique, rich, and defensible source of human genetic data from populations throughout the world.
MOTIF BIOSCIENCES
Industry:
Biotechnology Genetics Health Care
Founded:
2003-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.motifbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.44 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Hosting COVID-19 Cloudflare DNS Wufoo Intermedia Hosting
Similar Organizations
Color
Color is a complete platform for healthcare delivery.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Stock Details
Investors List
Amphion Innovations
Amphion Innovations investment in Series C - Motif BioSciences
Amphion Innovations
Amphion Innovations investment in Venture Round - Motif BioSciences
Official Site Inspections
http://www.motifbio.com
- Host name: 172.67.174.107
- IP address: 172.67.174.107
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Motif BioSciences"
Motif BioSciences - Crunchbase Company Profile & Funding
Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases using human genetic data from individuals. View contacts for Motif BioSciences to …See details»
Motif Bio Company Profile 2024: Valuation, Funding
Motif Bio PLC is a cash shell company. Want detailed data on 3M+ companies? What you see here scratches the surface. Want to dig into this profile? We’ll help you find what you need. This information is available in the PitchBook …See details»
Motif Bio Company Profile - Office Locations, Competitors ... - Craft
May 26, 2021 · Motif Bio PLC is a United Kingdom-based clinical-stage biopharmaceutical company which specializes in developing antibiotics designed to be effective against serious …See details»
MotifBio - VentureRadar
Offers a platform for biopharmaceutical investments as an AIM Rule 15 cash shell, following restructuring; shares suspended, pending a transaction. "Motif Bio plc (“Motif Bio”, “the …See details»
Motif BioSciences Inc - Company Profile and News
Motif BioSciences Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing novel antibiotics designed to be effective against infections caused by …See details»
Motif BioSciences - Funding, Financials, Valuation & Investors
Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases using human genetic data from individuals.See details»
Motif BioSciences - Products, Competitors, Financials, Employees ...
Motif BioSciences is developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. Motif has a lead antibiotic …See details»
Motif Bio : 2020 Annual Report and Accounts - MarketScreener
May 10, 2021 · Motif Bio plc (AIM: MTFB) announces that the 2020 Annual Report and Accounts are available for download from the Company's website at www.motifbio.com. Motif Bio is a …See details»
Motif Bio PLC - Company Profile and News - Bloomberg Markets
Motif Bio PLC operates as a clinical stage biopharmaceutical company. The Company specializes in the development of antibiotics designed to be effective against serious and life-threatening...See details»
Motif Bio PLC, Spero Therapeutics, Inc. and Vical Incorporated Join ...
Jan 29, 2018 · Motif Bio PLC (AIM/Nasdaq: MTFB), is a clinical-stage biopharmaceutical company focused on developing novel antibiotics to treat hospitalized patients with serious and life …See details»
Motif Bio plc Company Information - Drugs.com
Mar 2, 2016 · Motif Bio plc was a clinical-stage biopharmaceutical company focused on developing novel antibiotics. The company’s lead product candidate was iclaprim, an …See details»
Motif Bio CEO and Key Executive Team | Craft.co
Motif Bio's Chairman is Bruce Williams. Other executives include Jonathan E. Gold, President and Chief Business Officer; Graham Lumsden, Non-Executive Director. See the full leadership …See details»
MTFB - Motif Bio Plc Stock Price - Barchart.com
Motif Bio plc is a biopharmaceutical company. It engaged in the research and development of antibiotics for serious and life-threatening infections caused by multi-drug resistant bacteria. …See details»
Motif Bio plc | Insights
Jun 6, 2019 · The under-pressure UK biotech, Motif Bio PLC , has presented more clinical data on its lead Gram-positive targeted investigational antibacterial, iclaprim, as it prepares for a …See details»
MTFB: Initiating Coverage of Motif Bio Plc; Novel Antibiotic With ...
Sep 5, 2017 · We are initiating coverage of Motif Bio Plc (MTFB) with a $28 valuation. Motif is a biopharmaceutical company developing novel antibiotic treatments for patients with life …See details»
Motif Bio: Lessons from a failed pharma - Investors Chronicle
Jun 16, 2021 · It happened again this week at Motif Bio (MTFB). The company was due to go through a reverse takeover that would heavily dilute existing shareholders, but the necessary …See details»
Motif Bio plc Stock (MTFB) - Quote London S.E.- MarketScreener
May 21, 2010 · Motif Bio plc (MTFB.LON): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Motif Bio plc | London S.E.: MTFB | London S.E.See details»
Motif Bio Plc (MTFB.L) Share Price & News - Vox Markets
Jun 20, 2021 · Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB) is a clinical-stage biopharmaceutical company focused on developing novel antibiotics for hospitalised patients and designed to be …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
Modifi Bio Home - Modifi Bio
Modifi Bio is a preclinical stage biotechnology company creating a new class of molecules, designed to be delivered orally, that aim to selectively kill cancer cells via direct cancer DNA …See details»